A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007).

Saved in:
Bibliographic Details
Title: A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007).
Authors: Wang, Chenguang1,2,3,4 (AUTHOR), Zhou, Chaoxin1,2,3,4 (AUTHOR), Hou, Sheng1,2,3,4 (AUTHOR), Fan, Wenqiang1,4 (AUTHOR), Qian, Weizhu1,2,3,4 (AUTHOR), Ren, Yule1,2,3,4 (AUTHOR), Chen, Xiyuan4 (AUTHOR), Pan, Chenhong4 (AUTHOR), Guo, Qingcheng1,2,3,4 (AUTHOR), Guo, Huaizu1,2,3 (AUTHOR), Guo, Yajun1,2,3 (AUTHOR)
Source: Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p724. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194117548
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wang%2C+Chenguang%22">Wang, Chenguang</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Chaoxin%22">Zhou, Chaoxin</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hou%2C+Sheng%22">Hou, Sheng</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fan%2C+Wenqiang%22">Fan, Wenqiang</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qian%2C+Weizhu%22">Qian, Weizhu</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ren%2C+Yule%22">Ren, Yule</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Xiyuan%22">Chen, Xiyuan</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Chenhong%22">Pan, Chenhong</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Qingcheng%22">Guo, Qingcheng</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Huaizu%22">Guo, Huaizu</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Yajun%22">Guo, Yajun</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pharmaceuticals+%2814248247%29%22">Pharmaceuticals (14248247)</searchLink>. May2026, Vol. 19 Issue 5, p724. 17p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194117548
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ph19050724
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 17
        StartPage: 724
    Titles:
      – TitleFull: A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, Chenguang
      – PersonEntity:
          Name:
            NameFull: Zhou, Chaoxin
      – PersonEntity:
          Name:
            NameFull: Hou, Sheng
      – PersonEntity:
          Name:
            NameFull: Fan, Wenqiang
      – PersonEntity:
          Name:
            NameFull: Qian, Weizhu
      – PersonEntity:
          Name:
            NameFull: Ren, Yule
      – PersonEntity:
          Name:
            NameFull: Chen, Xiyuan
      – PersonEntity:
          Name:
            NameFull: Pan, Chenhong
      – PersonEntity:
          Name:
            NameFull: Guo, Qingcheng
      – PersonEntity:
          Name:
            NameFull: Guo, Huaizu
      – PersonEntity:
          Name:
            NameFull: Guo, Yajun
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 14248247
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Pharmaceuticals (14248247)
              Type: main
ResultId 1